First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an ETF managed by First Trust. Its largest position is JOHNSON & JOHNSON (JNJ), representing 7.45% of fund assets.
First Trust Nasdaq Pharmaceuticals ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FTXH
- Type:
- ETF
- Manager:
- First Trust
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 21, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
JOHNSON & JOHNSON
|
7.45% | $2,173,804.92 | 8,893 |
|
-
BRISTOL MYERS SQUIBB CO
|
7.36% | $2,148,344.30 | 35,422 |
|
-
Merck & Co., Inc.
|
7.36% | $2,146,334.47 | 17,843 |
|
-
AbbVie Inc.
|
7.10% | $2,070,504.80 | 9,520 |
|
-
ELI LILLY & Co
|
6.62% | $1,931,517.00 | 2,100 |
|
-
PFIZER INC
|
3.85% | $1,121,824.08 | 39,951 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
3.74% | $1,091,740.32 | 1,413 |
|
-
BIOGEN INC.
|
3.62% | $1,055,797.47 | 5,759 |
|
-
GILEAD SCIENCES, INC.
|
3.54% | $1,033,567.92 | 7,416 |
|
-
CARDINAL HEALTH INC
|
3.49% | $1,018,302.89 | 4,819 |
|
-
AMGEN INC
|
3.43% | $1,001,365.10 | 2,846 |
|
-
Viatris Inc
|
3.43% | $999,591.39 | 73,989 |
|
-
Zoetis Inc.
|
3.41% | $996,037.46 | 8,426 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
3.40% | $992,658.42 | 2,223 |
|
-
UNITED THERAPEUTICS Corp
|
3.31% | $966,557.40 | 1,630 |
|
-
INCYTE CORP
|
2.21% | $644,063.16 | 6,843 |
|
-
Jazz Pharmaceuticals plc
|
2.17% | $632,750.35 | 3,347 |
|
-
ILLUMINA, INC.
|
1.55% | $450,761.82 | 3,657 |
|
-
EXELIXIS, INC.
|
1.51% | $440,866.31 | 10,279 |
|
-
Medpace Holdings, Inc.
|
1.42% | $415,364.35 | 865 |
|
-
PTC THERAPEUTICS, INC.
|
1.27% | $371,240.37 | 5,449 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
1.26% | $366,907.50 | 2,127 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.22% | $356,903.82 | 6,318 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.19% | $346,476.20 | 2,630 |
|
-
HALOZYME THERAPEUTICS, INC.
|
1.11% | $323,473.15 | 5,005 |
|
-
Alkermes plc.
|
1.02% | $296,316.80 | 8,380 |
|
-
Elanco Animal Health Inc
|
0.90% | $261,435.25 | 10,925 |
|
-
Spyre Therapeutics, Inc.
|
0.61% | $178,204.52 | 3,533 |
|
-
Protagonist Therapeutics, Inc
|
0.60% | $173,910.00 | 1,650 |
|
-
TG THERAPEUTICS, INC.
|
0.57% | $167,727.78 | 5,049 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.56% | $163,709.70 | 2,611 |
|
-
CATALYST PHARMACEUTICALS INC
|
0.56% | $162,995.08 | 6,583 |
|
-
Amneal Pharmaceuticals, Inc.
|
0.55% | $161,391.12 | 12,984 |
|
-
Arcus Biosciences, Inc.
|
0.55% | $161,114.40 | 7,459 |
|
-
Twist Bioscience Corp
|
0.53% | $153,869.76 | 3,238 |
|
-
LIGAND PHARMACEUTICALS INC
|
0.52% | $152,931.90 | 766 |
|
-
Mirum Pharmaceuticals, Inc.
|
0.52% | $152,057.48 | 1,646 |
|
-
Travere Therapeutics, Inc.
|
0.52% | $151,521.00 | 5,100 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
0.52% | $150,876.72 | 456 |
|
-
Guardant Health, Inc.
|
0.51% | $149,454.66 | 1,618 |
|
-
Roivant Sciences Ltd.
|
0.50% | $145,425.00 | 5,250 |
|
-
Moderna, Inc.
|
0.49% | $144,068.80 | 2,836 |
|
-
SUPERNUS PHARMACEUTICALS, INC.
|
0.49% | $143,491.44 | 2,776 |
|
-
Krystal Biotech, Inc.
|
0.49% | $142,334.32 | 551 |
|
-
Tarsus Pharmaceuticals, Inc.
|
0.48% | $141,141.80 | 2,012 |
|
-
IONIS PHARMACEUTICALS INC
|
0.48% | $140,568.48 | 1,872 |
|
-
10x Genomics, Inc.
|
0.48% | $139,926.93 | 6,591 |
|
-
Kymera Therapeutics, Inc.
|
0.47% | $138,511.27 | 1,663 |
|
-
ACADIA PHARMACEUTICALS INC
|
0.47% | $137,700.36 | 6,186 |
|
-
Arcutis Biotherapeutics, Inc.
|
0.45% | $132,713.48 | 5,633 |
Advertisement (320x50)